{"document_type": "article", "byline": {"person": [{"firstname": "Michael", "organization": "", "lastname": "de la MERCED", "role": "reported", "rank": 1, "middlename": "J."}], "original": "By MICHAEL J. de la MERCED"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/10/12/business/12db-zymergen/12db-zymergen-thumbWide.jpg", "legacy": {"wide": "images/2016/10/12/business/12db-zymergen/12db-zymergen-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/10/12/business/12db-zymergen/12db-zymergen-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/12/business/12db-zymergen/12db-zymergen-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/10/12/business/12db-zymergen/12db-zymergen-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/12/business/12db-zymergen/12db-zymergen-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"main": "Zymergen Raises $130 Million in New Round of Financing"}, "print_page": null, "keywords": [{"value": "Venture Capital", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Microbiology", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Start-ups", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "SOFTBANK Corporation", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Chu, Steven", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "San Francisco (Calif)", "is_major": "N", "rank": "6", "name": "glocations"}], "snippet": "The new round of financing in the start-up, which has focused on helping genetically engineer tiny microbes, was led by SoftBank of Japan....", "source": "The New York Times", "lead_paragraph": "The new round of financing in the start-up, which has focused on helping genetically engineer tiny microbes, was led by SoftBank of Japan.", "word_count": "487", "pub_date": "2016-10-12T04:00:00+0000", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/10/12/business/dealbook/zymergen-softbank-series-b-financing.html", "_id": "57fc8b0095d0e021d798b319"}